BRIEF published on 02/17/2026 at 07:35, 8 months 12 days ago Leadership Transition at Sensorion amid Strategic Focus on Hearing Loss Therapies Biotechnology Gene Therapy Leadership Change Sensorion Hearing Loss
BRIEF published on 02/17/2026 at 07:35, 8 months 12 days ago Transition de direction chez Sensorion dans un contexte de recentrage stratégique sur les thérapies contre la perte auditive Biotechnologie Thérapie Génique Changement De Leadership Sensorion Perte Auditive
PRESS RELEASE published on 02/17/2026 at 07:30, 8 months 12 days ago Informations privilégiées / Autres communiqués Sensorion annonce des changements dans sa direction avec le départ de Nawal Ouzren et la prise de fonction par Amit Munshi en tant que Directeur Général par intérim Direction Sensorion Changements Amit Munshi Nawal Ouzren
PRESS RELEASE published on 02/17/2026 at 07:30, 8 months 12 days ago Inside Information / Other news releases Sensorion announces Nawal Ouzren stepping down as CEO for personal reasons. Amit Munshi to serve as Interim CEO. Sanofi-led financing for pipeline assets Leadership Changes Sanofi Sensorion Amit Munshi Nawal Ouzren
BRIEF published on 02/06/2026 at 07:35, 8 months 23 days ago Sensorion to Participate in ARO 49th Annual Midwinter Meeting Biotechnology Gene Therapy Sensorion Hearing Loss ARO Meeting
BRIEF published on 02/06/2026 at 07:35, 8 months 23 days ago Sensorion participera à la 49e réunion annuelle d'hiver de l'ARO. Biotechnologie Thérapie Génique Sensorion Perte Auditive Réunion ARO
PRESS RELEASE published on 02/06/2026 at 07:30, 8 months 23 days ago Informations privilégiées / Autres communiqués Sensorion participe à la 49ème rencontre annuelle de l’ARO pour présenter sa nouvelle thérapie génique SENS-601 pour la surdité autosomique récessive non syndromique 1A Thérapie Génique Sensorion Perte Auditive Surdité ARO
PRESS RELEASE published on 02/06/2026 at 07:30, 8 months 23 days ago Inside Information / Other news releases Sensorion to present SENS-601 gene therapy at ARO 49th Annual Midwinter Meeting in Puerto Rico Gene Therapy Sensorion Hearing Loss SENS-601 ARO 49th Annual Midwinter Meeting
BRIEF published on 01/28/2026 at 07:48, 9 months 4 days ago Sensorion Secures €60 Million Financing to Advance Hearing Loss Therapies Gene Therapy Biotech Financing Sensorion Hearing Loss Sanofi Investment
BRIEF published on 01/28/2026 at 07:48, 9 months 4 days ago Sensorion obtient un financement de 60 millions d'euros pour faire progresser les thérapies contre la perte auditive Thérapie Génique Sensorion Perte Auditive Financement Des Biotechnologies Investissements Sanofi
Published on 10/30/2026 at 23:35, 2 days 6 hours ago Prospect Ridge Announces Closing of Critical Metals Flow-through Unit Private Placement
Published on 10/30/2026 at 23:30, 2 days 6 hours ago Revolve Enters into Definitive Agreement to Acquire Three Project, 6 MW Battery Storage Portfolio in Ontario
Published on 10/30/2026 at 19:00, 2 days 10 hours ago Electric Royalties Ltd. Announces Application for Warrant Extension
Published on 10/30/2026 at 15:30, 2 days 14 hours ago Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split
Published on 11/01/2026 at 10:35, 19 hours 1 minute ago Shenzhen Unveils APEC China 2026 Host-City Theme Song and Music Video
Published on 11/01/2026 at 05:00, 1 day ago 2026 Yangtze River Culture Festival Opens in Yonglian Village, Zhangjiagang, Jiangsu
Published on 10/31/2026 at 16:35, 1 day 13 hours ago SKYWORTH Solar Announces Global Launch of Solavita as a Smart Microgrid Brand
Published on 10/30/2026 at 22:49, 2 days 6 hours ago EQS-Adhoc: STRATEC SELLS LOSS-MAKING BUSINESS, RECOGNIZES IMPAIRMENTS, AND AMENDS GUIDANCE
Published on 10/30/2026 at 23:00, 2 days 6 hours ago BIOPHYTIS REPORTS FIRST- HALF 2026 RESULTS AND PROVIDES AN UPDATE ON ITS STRATEGY
Published on 10/30/2026 at 23:00, 2 days 6 hours ago Biophytis publie les résultats du premier semestre 2026 et fait le point sur sa stratégie
